DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Mohit Sodhi - 2 semaglutide - 1 – - 1 Ozempic - 1 ” - 1 Mahyar - 1 — - 1 It’s - 1
Top related locs:
U.S University of British Columbia Australia Novo
Top related orgs:
Novo Nordisk - 2 Blockbuster - 1 JAMA - 1 University of British Columbia - 1 Nordisk - 1 CNN - 1 University of British - 1 US Food and Drug Administration - 1

Search resuls for: "Mohit Sodhi"


2 mentions found


☆ Weight loss drugs may be linked to stomach paralysis, other rare but severe issues, study says
  + stars: | 2023-10-05 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +2 min
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. Blockbuster weight loss and diabetes drugs like Wegovy and Ozempic may be associated with an increased risk of three rare, but severe, stomach conditions in non-diabetic patients, according to a new epidemiological study released Thursday. Their research is the first large, population-level study to examine the risk of serious stomach conditions in non-diabetic patients specifically using GLP-1s for weight loss. People with diabetes are also at increased risk of experiencing stomach paralysis and pancreatitis overall, even without the treatments.
Persons: semaglutide, –, Mohit Sodhi Organizations: Blockbuster, JAMA, Novo Nordisk, University of British Columbia, Nordisk Locations: U.S
☆ Researchers link popular weight loss drugs to serious digestive problems for ‘hundreds of thousands’ worldwide
  + stars: | 2023-10-05 | by ( Brenda Goodman | ) edition.cnn.com   time to read: +11 min
They can help people with diabetes control their blood sugar and lead to substantial weight loss for people with or without diabetes. Liraglutide was FDA approved as a weight loss medicine since 2014. What’s been less clear is whether patients taking these drugs for weight loss may have the same serious side effects. CNN reached out to Novo Nordisk, the manufacturer of both injectable weight loss drugs examined in this study, for comment. Sodhi said they started the man on a medication that treats stomach paralysis, “and he got a lot better,” Sodhi said.
Persons: Ozempic, ”, Mahyar, —, It’s, Liraglutide, it’s, Mohit Sodhi, Sodhi, Ian Musgrave, Musgrave, What’s, “, ” Sodhi, Dr, Sanjay Gupta Organizations: CNN, University of British, US Food and Drug Administration, FDA, “, University of Adelaide, Science Media Centre, BMI, Novo Nordisk, CNN Health Locations: University of British Columbia, Australia, Novo
0 next >>
Total: 2